Get started
Author

Susana Millán

Efficacy of Single-Dose Antibiotic Against Early-Onset Pneumonia in Comatose Patients Who Are Ventilated
2013 · Jordi Vallés, Raquel Peredo, et al. · CHEST Journal · 84
Bevacizumab biosimilar BEVZ92 versus reference bevacizumab in combination with FOLFOX or FOLFIRI as first-line treatment for metastatic colorectal cancer: a multicentre, open-label, randomised controlled trial
2018 · Alvaro Romera, Sergiy Peredpaya, et al. · The Lancet. Gastroenterology & hepatology · 63
RBD-specific polyclonal F(ab´)2 fragments of equine antibodies in patients with moderate to severe COVID-19 disease: A randomized, multicenter, double-blind, placebo-controlled, adaptive phase 2/3 clinical trial
2021 · Gustavo Lopardo, Waldo H. Belloso, et al. · EClinicalMedicine · 48
PDF
Comparative assessment of pharmacokinetics, and pharmacodynamics between RTXM83™, a rituximab biosimilar, and rituximab in diffuse large B-cell lymphoma patients: a population PK model approach
2018 · Myrna Candelaria, Derlis Gonzalez, et al. · Cancer Chemotherapy and Pharmacology · 42
PDF
Efficacy, Safety and Immunogenicity of MB02 (Bevacizumab Biosimilar) versus Reference Bevacizumab in Advanced Non-Small Cell Lung Cancer: A Randomized, Double-Blind, Phase III Study (STELLA)
2021 · Dmytro Trukhin, Elena Poddubskaya, et al. · BioDrugs · 27
PDF
Phase II study of plitidepsin in pretreated patients with locally advanced or metastatic non-small cell lung cancer
2007 · Christian Peschel, Joerg T. Hartmann, et al. · Lung Cancer · 25
Current State and Comparison of the Clinical Development of Bevacizumab, Rituximab and Trastuzumab Biosimilars
2021 · Luis Pérez Díaz, Susana Millán, et al. · Future Oncology · 14
Development of RTXM83 (a potential rituximab biosimilar): In vitro and in vivo comparability with MabThera.
2014 · Mauricio Seigelchifer, Esteban Corley, et al. · Journal of Clinical Oncology · 11
Clinical Pharmacokinetic (PK) and Safety (Immunogenicity) of Rituximab Biosimilar RTXM83 in Combination with Chemotherapy CHOP in Patients with Diffuse Large B-Cell Lymphoma (DLBCL)
2014 · Amalia Florez, Thiago Di Matteo, et al. · Blood · 8
Results of bevacizumab biosimilar compared with RMP for the treatment of metastatic colorectal cancer.
2017 · Enrique Luis Roca, Yuriy Vinnyk, et al. · Journal of Clinical Oncology · 3
Phase III Study to Confirm Clinical Similarity of MB09, a Denosumab Biosimilar, and Prolia® in Postmenopausal Women with Osteoporosis (SIMBA Study)
2026 · Jerzy Supronik, Elene Giorgadze, et al. · Pharmaceutics · 1
PDF
Bevacizumab biosimilar and reference bevacizumab in subjects with stage IIIB/IV no squamous non-small cell lung cancer (NSCLC) (STELLA study): Results for the primary endpoint in a confirmatory, double-blind, randomized, controlled study.
2020 · Susana Millan, Dmytro Trukhin, et al. · Journal of Clinical Oncology · 1
Bevacizumab biosimilar and reference bevacizumab in subjects with stage IIIB/IV non-squamous non-small cell lung cancer (STELLA): Design of a confirmatory, double-blind, randomized, controlled study.
2019 · Yaroslav V. Shparyk, Igor Bondarenko, et al. · Journal of Clinical Oncology · 1
Study of RTXM83 plus CHOP chemotherapy versus a rituximab plus CHOP therapy in patients with Non Hodgkin?s lymphoma
2013 · Susana Millan · 1
Estudio del efecto de la aplicación sistemática de pamidronato disódico y ácido zoledrónico en hueso mandibular en un modelo de experimentación animal
2016 · Susana Millán · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
PDF
Works count: 15
Citation count: 329
H-index: 8
I10-index: 8
Year
Topic
Type